| 发明名称 |
Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 摘要 |
<p>Muscle degenerative diseases can be detected in the early stage and the therapeutic efficacy of a therapeutic agent and/or a therapy method for the diseases can be determined by measuring 11,15-dioxo-9α-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid (referred to as "Tetranor-PGDM", hereinbelow) in a sample isolated from a subject.</p> |
| 申请公布号 |
AU2010222123(A1) |
申请公布日期 |
2011.09.15 |
| 申请号 |
AU20100222123 |
申请日期 |
2010.03.08 |
| 申请人 |
OSAKA BIOSCIENCE INSTITUTE;TAIHO PHARMACEUTICAL CO., LTD.;NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY |
发明人 |
URADE, YOSHIHIRO;ARITAKE, KOSUKE;MARUYAMA, TOSHIHIKO;KAMAUCHI, SHINYA;TAKEDA, SHIN'ICHI;NAKAMURA, AKINORI |
| 分类号 |
G01N33/53;G01N27/62;G01N30/72;G01N30/88;G01N33/15;G01N33/50 |
主分类号 |
G01N33/53 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
